Back
Hydrofarm Holdings Group Vs. Akero Therapeutics Industry Stock Comparison
Sell
31
HYFM
Hydrofarm Holdings Group
Last Price:
$3.70
Seasonality Move:
-18.89%
Buy
66
AKRO
Akero Therapeutics
Last Price:
$54.55
Seasonality Move:
26.74%
Sell
31
Hydrofarm Holdings Group (HYFM)
is a Sell
Is Hydrofarm Holdings Group a Buy, Sell or Hold?
-
The current Hydrofarm Holdings Group [HYFM] share price is $3.79. The Score for HYFM is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
HYFM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
66
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $54.71. The Score for AKRO is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HYFM Stock Price Chart
What is Hydrofarm Holdings Group's stock price today?
-
The Hydrofarm Holdings Group share price today is $3.79The current trend is moderately bullish and HYFM is experiencing slight selling pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $54.71Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight buying pressure.
HYFM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.18 | Buy |
Relative Strength Index (14 RSI): | 58.02 | Buy |
Chaikin Money Flow: | -2121 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.29 - 3.95) | Buy |
Bollinger Bands (100): | (2.41 - 5.49) | Sell |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.25 | Buy |
Relative Strength Index (14 RSI): | 71.1 | Buy |
Chaikin Money Flow: | 33208 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.6 - 51.14) | Buy |
Bollinger Bands (100): | (35.32 - 51.52) | Buy |
HYFM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.74 | Buy |
20-day SMA: | 3.51 | Buy |
50-day SMA: | 2.95 | Buy |
200-day SMA: | 5.18 | Sell |
8-day EMA: | 3.71 | Buy |
20-day EMA: | 3.55 | Buy |
50-day EMA: | 3.44 | Buy |
200-day EMA: | 5.11 | Sell |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 51.99 | Buy |
20-day SMA: | 46.75 | Buy |
50-day SMA: | 42.7 | Buy |
200-day SMA: | 36.23 | Buy |
8-day EMA: | 52.06 | Buy |
20-day EMA: | 48.42 | Buy |
50-day EMA: | 44.97 | Buy |
200-day EMA: | 37.92 | Buy |
Hydrofarm Holdings Group Earnings Growth & HYFM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.30 per share, an increase this year of $1.90 per share, and an increase next year of $0.90 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.
Hydrofarm Holdings Group Technical Analysis
May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |